Literature DB >> 3584110

Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy.

W J Burtis, T Wu, C Bunch, J J Wysolmerski, K L Insogna, E C Weir, A E Broadus, A F Stewart.   

Abstract

Humoral hypercalcemia of malignancy is a common paraneoplastic syndrome which is characterized by hypercalcemia resulting from secretion by tumors of a circulating bone-resorbing factor. Evidence suggests that in many instances this factor is an adenylate cyclase-stimulating protein which shares features with, but is distinct from, parathyroid hormone (PTH). The current report describes the purification to homogeneity from a humoral hypercalcemia of malignancy-associated tumor of a novel, basic, highly potent PTH-like adenylate cyclase-stimulating protein. This factor differs from previously described PTH-like factors with respect to size, amino acid composition, and specific activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584110

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

Review 1.  Hypercalcemia of malignancy.

Authors:  V Grill; T J Martin
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  PTHrP 1-141 and 1-86 increase in vitro bone formation.

Authors:  Blake Eason Hildreth; Jillian L Werbeck; Nandu K Thudi; Xiyun Deng; Thomas J Rosol; Ramiro E Toribio
Journal:  J Surg Res       Date:  2010-03-16       Impact factor: 2.192

3.  Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy.

Authors:  M Mangin; A C Webb; B E Dreyer; J T Posillico; K Ikeda; E C Weir; A F Stewart; N H Bander; L Milstone; D E Barton
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  Parathyroid hormone-related protein activates Wnt signaling to specify the embryonic mammary mesenchyme.

Authors:  Minoti Hiremath; Pamela Dann; Jennifer Fischer; Daniela Butterworth; Kata Boras-Granic; Julie Hens; Joshua Van Houten; Wei Shi; John Wysolmerski
Journal:  Development       Date:  2012-10-03       Impact factor: 6.868

5.  Prognostic value of immunocytochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course.

Authors:  Paweł Surowiak; Piotr Dziegiel; Rafał Matkowski; Mirosław Sopel; Andrzej Wojnar; Jan Kornafel; Maciej Zabel
Journal:  Virchows Arch       Date:  2003-01-25       Impact factor: 4.064

6.  Age-related decrease in the effect of parathyroid hormone-related protein on cytosolic free calcium level and tension in rat aortic smooth muscle.

Authors:  M Ishikawa; Y Ouchi; M Akishita; K Kozaki; K Toba; A Namiki; T Yamaguchi; H Ito; H Orimo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

7.  PTHrP is a novel mediator for TGF-β-induced apoptosis.

Authors:  Yanna Cao; Weili Zhang; Xuxia Gao; Guohua Zhang; Miriam Falzon; Courtney M Townsend; Mark R Hellmich; Tien C Ko
Journal:  Regul Pept       Date:  2013-03-13

8.  Parathyroid hormone-related protein: primary osteolytic factor produced by breast tumor cells in vitro?

Authors:  A Tabuenca; S Mohan; C A Garberoglio; P I Borgen; T Rosol; T A Linkhart
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 9.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

Review 10.  Understanding and targeting osteoclastic activity in prostate cancer bone metastases.

Authors:  J L Sottnik; E T Keller
Journal:  Curr Mol Med       Date:  2013-05       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.